ENBIOSIS BIOTECHNOLOGIES
2 clinical trials · Sponsor
◉ Watch ENBIOSIS BIOTECHNOLOGIES
| Record | Firm | Date |
|---|---|---|
| AIM-IBD: A Microbiome-Targeted Supplement in Mild-to-Moderate Ulcerative Colitis (NCT07619638) | ENBIOSIS BIOTECHNOLOGIES | 2026-06-10 |
| AIM-MET: AI-Guided Microbiome-Targeted Nutrition for Glycemic Improvement in Type 2 Diabetes (NCT07622628) | ENBIOSIS BIOTECHNOLOGIES | 2026-06-01 |
Track ENBIOSIS BIOTECHNOLOGIES automatically
Every clearance here is in the API, with alerts when new ones post.